Ayala Pharmaceuticals Inc
(ADXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2012 | 01-2012 | 10-2011 | 07-2011 | 04-2011 | |
| Operating Expenses | 3,230 | 3,244 | 0 | 3,597 | 3,408 |
| Operating Income | -3,230 | -3,244 | N/A | -3,597 | -3,408 |
| Interest Expense | 1,580 | 1,617 | 0 | 1,770 | 419 |
| Other Income | 2,200 | 149 | 0 | 9,008 | -5,808 |
| Pre-tax Income | -2,610 | -4,712 | 0 | 3,641 | -9,635 |
| Income Tax | N/A | -347 | N/A | N/A | N/A |
| Net Income Continuous | -2,610 | -4,366 | N/A | 3,641 | -9,635 |
| Net Income | $-2,610 | $-4,366 | $N/A | $3,641 | $-9,635 |
| EPS Basic Total Ops | -0.01 | -0.02 | N/A | 0.02 | -0.05 |
| EPS Basic Continuous Ops | -0.01 | -0.02 | N/A | 0.02 | -0.05 |
| EPS Diluted Total Ops | -0.01 | -0.02 | N/A | 0.01 | -0.05 |
| EPS Diluted Continuous Ops | -0.01 | -0.02 | N/A | 0.01 | -0.05 |
| EBITDA(a) | $-2,634 | $-2,662 | $N/A | $-3,246 | $-3,291 |